Pupose: Takotsubo cardiomyopathy is a rare and not well-known complication of the subarachnoid hemorrhage. This form of heart failure, called as "broke heart" or "apical ballooning syndrome", was first described by Japanese authors at the beginning of 1990's. 1.5-2.2% of acute coronary syndrome is Takotsubo cardiomyopathy. Its predisposing factors, hypothetical parthenogenesis, diagnostic criteria and therapeutic methods are already known from the literature. The study intends to include all patients over 18 years of age who were admitted to our clinic within 48 hours after the bleeding regardless of gender, neurological status or age. Data to be registered within 24 hours after admittance: Instruments: * Intracranial blood flow characteristics:TCCD - using Transcranial Color Doppler; systolic, diastolic and mean blood flow velocity, Systolic / Diastolic ratio, pulsatility index * ECG abnormalities: Corrected QT Interval (QTc), T wave, ST segment, arrhythmia * Echocardiography (Ejection fraction%, exact location and degree of cardiac wall motion abnormalities) - documented with video recording Hypothesis: The risk of Takotsubo cardiomyopathy (TS) is increased if SAH is associated with more severe state, a greater degree of bleeding, intraventricular and/ or intracerebral hemorrhage. The definitive care of patients is postponed due to the appearance of TS, which could affect the final outcome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
ECG abnormalities:Corrected QT Interval (QTc), T wave, ST segment, arrhythmia
Timeframe: Data to be registered within 24 hours after admittance
ECG abnormalities:Corrected QT Interval (QTc), T wave, ST segment, arrhythmia
Timeframe: The following diagnostic steps should be repeated after 1 month
urine metanephrine, normetanephrine levels
Timeframe: The amount of urine collected in 24 hours
urine metanephrine, normetanephrine levels
Timeframe: The following diagnostic steps should be repeated after 1 month
Enzyme level associated with myocardial tissue necrosis
Timeframe: Data to be registered within 24 hours after admittance
Enzyme level associated with myocardial tissue necrosis
Timeframe: The following diagnostic steps should be repeated after 1 month
Ejection fraction%, exact location and degree of cardiac wall motion abnormalities
Timeframe: Data to be registered within 24 hours after admittance
Ejection fraction%, exact location and degree of cardiac wall motion abnormalities
Timeframe: The following diagnostic steps should be repeated after 1 month